Picture Berlin Partner Events Bionnale 2025 May HealthCapital 650x100px

Document › Details

UCB S.A.. (2/28/19). "Press Release: UCB Full Year Report 2018. 2018 Marks the Fifth Consecutive Year of Profitable Growth, Intensifying Investment in UCB’s Strong Pipeline". Brussels.

	Organisation	UCB S.A. (Euronext: UCB)
	Group	UCB (Group)
	Product	Cimzia®
	Product 2	Vimpat®
	Person	Tellier, Jean-Christophe (UCB 201403– CEO-elect joined UCB 2011 before Ipsen + Macrogenics + Novartis)
	Person 2	Witte, Antje (UCB 201601 Investor Relations)

Original document
accessed by [iito] on 2019-03-01

Record changed: 2023-06-05

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for UCB (Group)

[1] TissUse GmbH. (5/28/24). "Press Release: Novel Liver Ring Trial Set to Revolutionize Drug Safety Assessment". Berlin....
[2] Ariceum Therapeutics GmbH. (5/11/23). "Press Release: UCB and Ariceum Therapeutics Sign a Strategic Research Collaboration to Discover New Modalities for the Treatment of Immune-related Diseases and Cancer". Berlin & Brussels....
[3] UCB S.A.. (3/15/23). "Press Release: Aitia and UCB Announce Strategic Drug Discovery Collaboration in Huntington's Disease". Brussels & Somerville, MA....
[4] UCB S.A.. (3/9/23). "Press Release: Cancer Research UK Signs Multi-Project Collaboration with UCB to Advance Oncology Antibody Candidates". Brussels & London....
[5] UCB S.A.. (3/9/23). "Press Release: UCB’s Board of Directors Appoints Jonathan Peacock as New Chair". Brussels....
[6] SpliceBio S.L.. (2/16/22). "Press Release: SpliceBio Raises EUR 50M in Oversubscribed Series A financing to Advance Protein Splicing Platform and Expand Gene Therapy Pipeline". Barcelona....
[7] UCB S.A.. (1/19/22). "Press Release: UCB to Acquire Zogenix". Brussels & Emeryville, CA....
[8] UCB S.A.. (12/2/21). "Press Release: UCB Announces Global Partnership to Bring Disease-modifying Therapies to People Living with Parkinson’s Disease". Brussels....
[9] UCB S.A.. (11/30/21). "Press Release: UCB and Chiesi Enter Global License Agreement for Zampilimab a Novel Monoclonal Antibody for Fibrotic Lung Diseases". Brussels & Parma....
[10] Atbtherapeutics. (10/5/21). "Press Release: Atbtherapeutics Expands Leadership Team and Scientific Advisory Board with Pharmaceutical Industry Experts". Aye....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]